trending Market Intelligence /marketintelligence/en/news-insights/trending/fnz8u24-ebi_2lwaxvqbnw2 content esgSubNav
In This List

Ionis Pharmaceuticals appoints chief business officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Ionis Pharmaceuticals appoints chief business officer

Ionis Pharmaceuticals Inc. appointed Damien McDevitt as chief business officer.

The Carlsbad, Calif.-based biotechnology company said McDevitt previously served as senior vice president of corporate development at ACADIA Pharmaceuticals Inc.

Prior to joining ACADIA, McDevitt worked at GlaxoSmithKline PLC in several roles for more than 20 years.